Ari Moskowitz, Lars W Andersen, Jon C Rittenberger, Robert Swor, Raghu R Seethala, Michael C Kurz, Katherine M Berg, Maureen Chase, Michael N Cocchi, Anne V Grossestreuer, Xiaowen Liu, Mathias J Holmberg, Clifton W Callaway, Michael W Donnino
Background Neuromuscular blockade (NMB) agents are often administered to control shivering during targeted temperature management following cardiac arrest. In this study, we hypothesized that early, continuous NMB would result in a greater reduction in serum lactate levels among comatose patients after cardiac arrest. Methods and Results Randomized trial of continuous NMB for 24 hours versus usual care following cardiac arrest conducted at 5 urban centers in the United States. Adult patients who achieved return of spontaneous circulation, remained unresponsive, and underwent targeted temperature management after cardiac arrest were included...
September 2020: Journal of the American Heart Association